Cambridge Healthtech Institute’s 5th Annual

Adoptive T Cell Therapy 1: Discovery

Engineering Immune Cells for More Effective Immunotherapies

August 28-29, 2018

Greater understanding of T cell biology as well as promising patient outcomes have led to immunotherapies accelerating at an unprecedented pace. However, with the end goal being the same – improved patient outcomes – there is still work to be done. Cambridge Healthtech Institute’s 5th Annual Adoptive T Cell Therapy 1: Discovery conference focuses on the steps needed to select, engineer, enhance, and deliver promising T cell therapies to the patient.

Preliminary Agenda


A Unique Approach to Adoptive Cell Therapy: Harnessing Super Immunity

Matthew Colpoys, PhD, CEO, Tactiva Therapeutics

Characterizing the Effects of Sex and Estrogen Signaling on the Function of Antigen-Specific T Cells for Immunotherapy

Flor Navarro, Research Scientist, Tumor Immunology, Loyola University Chicago

Simple Therapeutic Approach for Overcoming Solid Tumor Heterogeneity and Boosting T Cell Infiltration/Function

Shulin Li, PhD, Professor, Director, Pediatric Laboratory Research Programs, W.T. and Louise Jarrett Moran Distinguished Chair, Pediatric Oncology, Pediatric Research, MD Anderson Cancer Center


Mechanical Modality to Reengineer and Edit Cells for Enabling Cell/Gene Therapies

Steven Banerjee, CEO, Mekonos, Inc.

Intracellular Delivery Technology for Genome Editing

Shirley O'Dea, PhD, Co-Founder & CSO, Avectas

Orthogonal 2D Control of ACT: Not All Switches Are Created Equal

David M. Spencer, PhD, CTO, R&D, Bellicum Pharmaceuticals

Synthetic Biology in Cellular Immunotherapy

Wilson Wong, PhD, Assistant Professor, Biomedical Engineering, Boston University


Generation of Engineered Pluripotent Cell-Derived T Cells as a Cornerstone Approach for Off-the-Shelf Cancer Immunotherapy

Bob Valamehr, PhD, MBA, Vice President, Cancer Immunotherapy, Fate Therapeutics

For more details on the conference, please contact:
Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781-972-5497

For partnering and sponsorship information, please contact:
Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-247-6286